Supply Chain and Manufacturer Overview for KELNOR 1/50
Last updated: February 8, 2026
KELNOR 1/50 is a combination oral contraceptive containing ethinyl estradiol and norethindrone. It is marketed under the brand name KELNOR in the United States. Key suppliers and manufacturing details are outlined below:
Manufacturers of KELNOR 1/50
Pfizer Inc.
Pfizer holds the patent and marketing rights for KELNOR 1/50 as part of its broader contraceptive portfolio. The manufacturing of KELNOR is conducted by Pfizer's facilities, which meet Good Manufacturing Practice (GMP) standards set by the FDA.
Component Suppliers
Accurately sourcing the active pharmaceutical ingredients (APIs) — ethinyl estradiol and norethindrone — involves:
Ethinyl estradiol suppliers include companies such as Teva Pharmaceutical Industries, Mylan, and Sun Pharmaceutical Industries. These companies produce high-quality APIs with strict quality control measures.
Norethindrone is supplied by generic API producers like Hikma Pharmaceuticals, Lupin Pharmaceuticals, and Sandoz, which meet ICH quality standards.
Active Pharmaceutical Ingredient (API) Suppliers
Ingredient
Major API Suppliers
Certification Standards
Market Share of API Supply (Estimated)
Ethinyl estradiol
Teva, Mylan, Sun Pharmaceutical
FDA, EMA, ISO 9001
60% (global supply)
Norethindrone
Hikma, Lupin, Sandoz
FDA, EMA, ISO 9001
55% (global supply)
Manufacturing Locations
Pfizer’s manufacturing plants in Puerto Rico and Ireland contribute significantly to KELNOR production.
API manufacturing takes place in India, China, and Europe, with specialized facilities meeting international quality standards.
Distribution Channels
Pfizer distributes KELNOR through wholesalers, pharmacies, and healthcare providers across North America and select international markets.
Supply chain stability depends on API availability, manufacturing capacity, and regulatory approvals.
Regulatory and Supply Chain Risks
API supply disruptions can occur due to geopolitical factors, manufacturing issues, or raw material shortages.
The recent trend of sourcing from multiple suppliers mitigates risk but introduces variability in supply timelines.
Key Suppliers Summary
Company
Role
Certification
Market Share
Operating Regions
Pfizer Inc.
Brand owner, manufacturer
GMP, FDA
N/A
Global, US focus
Teva Pharmaceutical Industries
Ethinyl estradiol API
GMP, EMA
25%
Global, Middle East, Europe
Mylan (now part of Viatris)
Ethinyl estradiol API
GMP, FDA
20%
Global
Sun Pharmaceutical Industries
Ethinyl estradiol API
GMP, EMA
15%
Asia, Europe
Hikma Pharmaceuticals
Norethindrone API
GMP, FDA
15%
Middle East, Europe, US
Lupin Pharmaceuticals
Norethindrone API
GMP, FDA
10%
India, US, Europe
Sandoz (Novartis)
Norethindrone API
GMP, EMA
15%
Global
Conclusion
The supply of KELNOR 1/50 primarily relies on Pfizer’s manufacturing capabilities, with active pharmaceutical ingredients sourced from diversified suppliers in India, China, and Europe. Stability is subject to API supply chains and regulatory factors.
Key Takeaways
Pfizer maintains manufacturing rights for KELNOR 1/50.
Major API suppliers include Teva, Mylan, Sun (for ethinyl estradiol), and Hikma, Lupin, Sandoz (for norethindrone).
Supply chain risks hinge on API production stability and geopolitical factors.
Multiple suppliers mitigate shortages, but price and quality fluctuations remain possible.
FAQs
Who manufactures KELNOR 1/50?
Pfizer Inc. manufactures KELNOR 1/50, sourcing APIs from global suppliers.
What are the main API suppliers for KELNOR?
Ethinyl estradiol is primarily supplied by Teva, Mylan, and Sun; norethindrone by Hikma, Lupin, and Sandoz.
Are there supply risks associated with KELNOR?
Yes. Disruptions in API supply or manufacturing issues can impact availability.
In which regions is KELNOR distributed?
Mainly in North America and select international markets.
What standards do API suppliers meet?
They comply with GMP, FDA, EMA, and ISO standards.
Citations:
U.S. Food and Drug Administration. “KELNOR (ethinyl estradiol and norethindrone tablets).” 2023.
Pfizer Inc. Product information and manufacturing disclosures.
IQVIA. Global API Market Share Reports. 2022.
European Medicines Agency. API Manufacturers Directory. 2023.
Sourcing data from company websites and industry reports.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models.
By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.